ABVX
Abivax
ABVX
ABVX
252 hedge funds and large institutions have $5.53B invested in Abivax in 2026 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 111 increasing their positions, 75 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9.05% less ownership
Funds ownership: 72.25% → 63.2% (-9%)
18% less funds holding in top 10
Funds holding in top 10: 34 → 28 (-6)
27% less capital invested
Capital invested by funds: $7.61B → $5.53B (-$2.08B)
Holders
252
Holding in Top 10
28
Calls
$233M
Puts
$142M
Top Buyers
| 1 | +$120M | |
| 2 | +$37M | |
| 3 | +$34.3M | |
| 4 |
EP
Eversept Partners
New York
|
+$32.7M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$32.5M |
Top Sellers
| 1 | -$210M | |
| 2 | -$171M | |
| 3 | -$103M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$76.3M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$74.6M |
